U.S. patent application number 13/109047 was filed with the patent office on 2011-09-08 for method and apparatus for objective electrophysiological assessment of visual function.
This patent application is currently assigned to THE UNIVERSITY OF SYDNEY. Invention is credited to Stuart L. GRAHAM, Alexander KLISTORNER, Alex KOZLOVSKI, Iouri MALOV.
Application Number | 20110218456 13/109047 |
Document ID | / |
Family ID | 25646302 |
Filed Date | 2011-09-08 |
United States Patent
Application |
20110218456 |
Kind Code |
A1 |
GRAHAM; Stuart L. ; et
al. |
September 8, 2011 |
METHOD AND APPARATUS FOR OBJECTIVE ELECTROPHYSIOLOGICAL ASSESSMENT
OF VISUAL FUNCTION
Abstract
For electrophysiological assessment of visual function using a
head mounted stereo display (e.g. virtual reality goggles) for
displaying a stimulus which is used to generate a retinal or
cortical response. In particular, a method for objective
electrophysiological assessment of visual function of at least one
eye of a subject includes presenting a visual stimulus to at least
one eye of the subject, recording at least one of a retinal
response and, a cortical response generated as a result of the
presenting; analyzing said response and, as a result of said
analyzing, forming a map of the visual function of the at least one
eye of the subject 6. The invention also relates to as system for
such electrophysiological assessment.
Inventors: |
GRAHAM; Stuart L.; (West
Pymble, AU) ; MALOV; Iouri; (Turramurra, AU) ;
KOZLOVSKI; Alex; (Mt. Colah, AU) ; KLISTORNER;
Alexander; (Mt. Colah, AU) |
Assignee: |
THE UNIVERSITY OF SYDNEY
|
Family ID: |
25646302 |
Appl. No.: |
13/109047 |
Filed: |
May 17, 2011 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
12253331 |
Oct 17, 2008 |
7972278 |
|
|
13109047 |
|
|
|
|
10257565 |
Feb 25, 2003 |
7740592 |
|
|
PCT/AU2001/000423 |
Apr 12, 2001 |
|
|
|
12253331 |
|
|
|
|
Current U.S.
Class: |
600/558 |
Current CPC
Class: |
A61B 5/398 20210101;
A61B 5/378 20210101 |
Class at
Publication: |
600/558 |
International
Class: |
A61B 5/00 20060101
A61B005/00 |
Foreign Application Data
Date |
Code |
Application Number |
Apr 17, 2000 |
AU |
PQ6940 |
Dec 8, 2000 |
AU |
PR1982 |
Claims
1. An apparatusus for analysing at least one multifocal visual
evoked potential response of at least two subjects, the at least
one visual evoked potential response being induced by any mode of
multifocal stimulation, wherein the stimulation mode is adapted to
simultaneously stimulate different parts of the visual field of an
eye of the subject such that different parts of the visual field
are stimulated with random sequences of different timing or
character, the apparatus comprising: (a) electrodes placed on the
scalp or in contact with the eye of each subject configured to
simultaneously record (A) the at least one visual evoked potential
responses from each of the different parts of the visual field of
the eye and (B) the subject's overall spontaneous brain activity
levels; and (b) a computer configured to: (bi) identify, for each
subject, the alpha rhythm component in the subject's overall
spontaneous brain activity levels, (bii) remove, for each subject,
the alpha rhythm component from the subject's overall spontaneous
brain activity levels; (biii) calculate, for each subject, a
corresponding scaling factor, the scaling factor being derived from
the subject's overall spontaneous brain activity levels from which
the component of alpha rhythm is identified and removed; and (biv)
scale, for each subject, each subject's visual evoked potential
response using said each subject's scaling factor such that the
variability of the visual evoked potential responses induced by the
multifocal stimulation between the at least two subjects is
minimised.
2. The apparatus of claim 1, wherein the alpha rhythm component in
the subject's overall spontaneous brain activity levels is
identified by wave component analysis.
3. The apparatus of claim 2, wherein the alpha rhythm component in
the subject's overall spontaneous brain activity levels is
identified by Fourier analysis.
4. The apparatus of claim 1, wherein step (bi) comprises: for each
subject, using Fourier power spectrum analysis to determine the
subject's overall spontaneous brain activity levels, thereby to
calculate a scaling factor.
5. The apparatus of claim 1, wherein the multifocal stimulation
stimulates responses from different parts of the visual field of
both eyes of the subject and the responses from each of the
different parts of the visual field for each eye are recorded
simultaneously.
6. The apparatus of claim 1, wherein the computer is further
configured to: (bv) identify and remove the effect of
electrocardiogram spikes.
7. The apparatus of claim 3, wherein the electrocardiogram spikes
are identified by Fourier analysis of the subject's recorded
overall spontaneous brain activity levels.
8. The apparatus of claim 1, further comprising at least one of
storing and displaying said evoked potential response.
Description
TECHNICAL FIELD
[0001] This invention relates to the electrophysiological
assessment of visual function using a head mounted stereo display
(eg virtual reality goggles) for displaying a stimulus which is
used to generate a retinal or cortical response. In particular, the
integrity of the visual field can be assessed objectively by
measuring retinal or cortical responses to a multifocal visual
stimulus presented by a head mounted virtual reality display
instead of a conventional monitor. This provides advantages of
space, patient acceptance, standardising distance to the display,
and the possibility of monocular or binocular simultaneous
recording. The invention also describes scaling of the multifocal
visual evoked potential (VEP) signals according to background
electroencephalogram (EEG) levels, which reduces inter-individual
variability.
BACKGROUND ART
[0002] The objective assessment of the visual field using
multi-focal stimulation has been reported recently (refs 1-7).
Using different types of multifocal stimulus presentation (Sutter
U.S. Pat. No. 4,846,567; Malov, International Patent Application No
PCT/AU00/01483; and refs 14-17, the disclosures of which are hereby
being incorporated by reference), stimulation of a large number of
locations of the visual field can be performed simultaneously.
Visually evoked cortical potentials (VEP) and electroretinograms
(ERG) can be recorded from all areas of the field. For the VEP
various electrode placements have been used. The best
representation of the visual field was reported by the inventors
with multichannel bipolar recordings (Klistorner and Graham,
International Patent Application No. PCT/AU99/00340). Multifocal
ERG recording has been performed with various electrodes (gold
foil, DTL, Burian-Allen, gold lens). Good correlation was reported
between the multifocal VEP and visual field loss in glaucoma (refs
2, 5-7), and between the multifocal ERG and local retinal disease
(ref 8), but not between the multifocal ERG and glaucoma (ref 9,
10).
[0003] However, these recordings require a high resolution, large
screen display (22 inch or larger), and subjects are required to
sit close to the screen. The distance of the subject from the
screen changes the area of field stimulated, and also changes the
focal length and thus the required spectacle correction, so must be
closely controlled during the recording. The CRT monitor also
produces a large electromagnetic field which may affect the
recordings when the subject is in close proximity to the screen.
Recording is limited to one eye at the time, whereas with goggles
it is possible to present a different stimulus to the two eyes at
the same time. Therefore the concept of using a head mounted
display provides a solution to these problems, and saves
significantly on space requirements. It also allows for portability
of the system. Binocular simultaneous multifocal recording reduces
the recording time up to 50% by allowing two eyes to be tested
simultaneously using different stimulus sequences for the two
eyes.
[0004] A significant problem with multifocal VEP recordings has
been the large inter-individual variability seen among the normal
population, which limits the sensitivity of applying values from a
normal data base when looking for small changes early in the
disease process. A scaling algorithm has previously been reported
by us (Klistorner & Graham, International patent application
No. PCT/AU99/00340) which helped to reduce this variability.
However, the scaling of VEP amplitudes according to background
electroencephalogram levels as described in this patent has been
found to be a superior technique for reducing inter-individual
variability and increasing the sensitivity of the test.
DISCLOSURE OF THE INVENTION
[0005] The derivation of a functional map of the human visual field
can be achieved from analysis of either multifocal VEP or ERG
responses. The VEP responses tend to reflect losses at all stages
of the visual pathway, whereas the ERG responses tend to correlate
with local retinal disease. It has been demonstrated by Malov,
International Patent Application No PCT/AU00/01483 that using a
multifocal stimulus driven by a spread spectrum technique, (such
that different parts of the visual field are stimulated by
different random sequences), and by using appropriately placed
recording electrodes on the scalp with multiple recording channels,
that accurate maps of visual function can be recorded in the form
of multifocal pattern VEPs. Disease states such as glaucoma or
optic nerve disorders that cause blind spots in the vision (eg
optic neuritis in multiple sclerosis) can be detected and mapped.
Both amplitudes and latencies of the signals can be compared to
normal reference values or compared between the two eyes of a
subject.
[0006] We have found that a head mounted stereo display (eg virtual
reality goggles) can be applied to these recording techniques,
providing significant advantages. It reduces the space required in
the laboratory or test area by removing the need for a large
monitor. It makes the test potentially portable, and it
standardises the distance to the display reducing problems of
refraction, variable head position and thus area of field tested.
It removes the problem of electromagnetic noise emanating from the
screen when the subject sits close to the monitor. A head mounted
stereo display has good patient acceptance, and both monocular or
binocular recording can be performed.
[0007] Simultaneous binocular recording can be achieved with the
application of the spread spectrum technique (Malov, International
Patent Application No PCT/AU00/01483) and a head mounted stereo
display to provide different pseudorandom stimulus patterns to the
two eyes at the same time. The stimulus algorithm is divided into
twice the number of segments and these can be distributed between
the two eyes, still providing different stimulus sequences to each
part of the field and with each subsequent run. The
cross-correlations can derive VEP results from each eye
independently, with minimal auto-correlation of the signals within
or between eyes. This has the advantage of shortening the test time
significantly. It also standardises conditions of the recording
such that the two eyes are recorded under the same conditions in
terms of the subject's visual attention and extraneous noise
levels. This aids in the reliability of direct comparisons between
eyes of an individual.
[0008] The invention thus provides a method and apparatus for
objectively assessing the visual field using virtual reality
goggles to present a multifocal stimulus and then recording of
either retinal (ERG) or cortical (VEP) responses to that stimulus.
It includes simultaneous binocular recording of the VEP, using
different stimuli for the two eyes. It also includes a new scaling
method to reduce inter-subject variability in the recorded
multifocal VEP amplitudes by scaling the VEP response according to
overall electroencephalogram activity.
[0009] A suitable head mounted stereo display is what is commonly
known as virtual reality goggles. Other head mounted displays which
are able to present a suitable stimulus which can generate a
retinal or cortical response would also be appropriate.
[0010] "Virtual reality" is a term applied to the experience of an
individual when viewing through a head-mounted display an image
presented immediately before the eyes which has the appearance of
being viewed at a distance from the eye. Different images can be
presented to the two eyes to give a three dimensional effect.
[0011] It is a purpose of this invention to provide a method and
apparatus for recording of responses from multiple parts of the
visual field using virtual reality goggles, and thus provide a
compact, portable system that is acceptable for the patient and
clinician, and removes the need for close monitoring of recording
distances from the viewing screen.
[0012] According to one aspect of this invention there is provided
a method for objective electrophysiological assessment of visual
function of at least one eye of a patient, which method comprises
presenting a visual stimulus to at least one eye of the patient,
recording at least one resultant response, selected from the group
consisting of a retinal response and a cortical response, generated
as a result of the presenting; analysing said response; and as a
result of said analysing, forming a map of the visual function of
the at least one eye of the patient.
[0013] Usually, the presenting of the visual stimulus is achieved
by a head mounted display, in particular a head mounted stereo
display such as a head mounted virtual reality stereo display.
[0014] According to another aspect of this invention there is
provided a method for objective electrophysiological assessment of
visual function, which method comprises placing a head-mounted
stereo display for presenting a stimulus, on the head of a patient,
placing electrodes on the scalp or in contact with the eye of said
patient, connecting said head-mounted stereo display to a computer
which generates an algorithm for driving said stimulus; generating
said stimulus; recording the resultant retinal or cortical
responses generated as a result of the stimulus; amplifying and
analysing said responses; and as a result of said analysing,
forming a map of the visual function.
[0015] According to a further aspect of this invention there is
provided a method of identifying alpha-rhythm spikes or
electrocardiogram signals in raw data by application of Fourier
spectrum analysis. (It is important to identify these spikes prior
to scaling since they may alert the operator to lack of visual
attention of the patient.)
[0016] According to a still further aspect of this invention there
is provided a system for electrophysiological assessment of visual
function of at least one eye of a patient, comprising a
head-mounted stereo display for presenting a stimulus to at least
one eye of the patient; electrodes placed on the scalp or in
contact with the eye; a computer which generates an algorithm for
driving the stimulus; and a means for recording at least one
resultant response, selected from the group consisting of a retinal
response and a cortical response, generated as a result of
presenting said stimulus; and means for recording the resultant
retinal or cortical response; and software for analysing the
retinal or cortical response to said stimulus.
[0017] According to another aspect of this invention there is
provided a method for analysing at least one multifocal visual
evoked potential recording from any mode of multifocal stimulation
comprising scaling output from computer software according to
overall spontaneous brain activity levels (ie. electroencephalogram
levels) of a subject during the recording in order to minimise
inter-subject variability. The EEG scaling is more reliable if a
method for removing high alpha-rhythm signals or electrocardiogram
contamination is employed when calculating the background EEG
levels. The mode of multifocal stimulation includes conventional
CRT or LCD monitors or plasma screens for example.
[0018] As mentioned above, the head-mounted stereo display suitable
comprises virtual reality goggles. The head-mounted stereo display
may be used to derive a signal from the cortical visual evoked
potentials. It may also be used to derive an electroretinogram
signal from the eye. This display shows any type of multifocal
stimulation directly to the eye. The stimulus presented to the eye
may be a flash stimulus or a pattern stimulus. The stimulus may
vary in luminance, colour or stimulus duration to elicit visual
responses. The head-mounted stereo display suitably uses a liquid
crystal display or plasma screen, for example. The stimulus may be
presented monocularly or binocularly. The same stimulus may be
presented binocularly for simultaneously recording of signals from
both eyes. Where different stimuli are presented to the two eyes,
they may be simultaneously presented binocularly for simultaneous
recording to signals from the two eyes. For analysis of multifocal
visual evoked potential recordings, the results are scaled
according to the overall spontaneous brain activity (i.e.
electroencephalogram levels) of the subject during the recording to
minimise variability.
[0019] The invention utilises multifocal stimulation techniques.
Any multifocal stimulator (either existing equipment such as
ObjectiVision, VERIS, Retiscan, or future systems) can be used to
generate a stimulus which is then projected into virtual reality
goggles using monocular or binocular displays. We have established
that both the ObjectiVision and VERIS systems can be used in
recording with virtual reality goggles. The stimulus can be diffuse
(flash) or structured (pattern) and can vary in intensity, colour,
size or temporal characteristics. Appropriate electrodes placed on
the scalp for the VEP, or in the eye for the ERG, allow for
recording of the electrophysiological response, which is then
amplified by a conventional amplifier. Cross-correlation techniques
(eg, Malov, International Patent Application No PCT/AU00/01483)
allow for derivation of the signal from background noise. A
topographical map of the responses can then be derived
corresponding to the field of view of the subject. The output can
displayed as a printout of results, and comparisons made with a
normal data base of responses.
[0020] To reduce the inter-individual variability of the multifocal
VEP recordings the inventors have applied a scaling factor based on
background electroencephalogram (EEG) levels. Scaling of the VEP
amplitude based on amplitude of spontaneous brain activity
eliminates part of the variability between individuals caused by
differences in conductivity of underlying tissues (eg bone, muscle,
skin and subcutaneous fat). This also reduces the differences seen
between males and females, since it is known that women have
generally higher amplitude VEP signals when compared to men,
presumably due to sex differences in tissue thickness and
conductivity. Scaling according to EEG signals removes this
difference, rendering final signals equivalent between the sexes.
By reducing the range of variability between subjects it improves
the sensitivity of the test for detecting abnormality.
BRIEF DESCRIPTION OF THE DRAWINGS
[0021] A number of embodiments of the present invention will now be
described with reference to the drawings in which:
[0022] FIG. 1 is a schematic representation of the apparatus for
VEP recording including virtual reality goggles;
[0023] FIG. 2 is a schematic of the apparatus for ERG recording
including virtual reality goggles;
[0024] FIG. 3 is an example of a multifocal multichannel VEP
recording from a normal subject using conventional screen (FIG. 3A)
and goggles (FIG. 3B);
[0025] FIG. 4A shows the printout from a subjective Humphrey visual
field test with a scotoma demonstrated in the inferior visual field
of the right eye of a glaucoma patient;
[0026] FIG. 4B shows a multifocal multichannel VEP recording using
virtual reality goggles from the same eye as in FIG. 4A;
[0027] FIG. 5 shows the correlation between multifocal VEP
amplitude and electroencephalogram (EEG) levels during
recording;
[0028] FIG. 6A shows an example of normal Fourier spectrum of EEG
used for scaling VEP results;
[0029] FIG. 6B shows a trace with strong alpha-rhythm activity
around 8 Hz which must be removed before scaling (for example by
using a polynomial algorithm); and
[0030] FIG. 6C shows rhythmic electrocardiogram spikes which also
need to be excluded.
DESCRIPTION OF THE INVENTION
[0031] FIG. 1 shows a schematic of the apparatus for VEP recording
using virtual reality goggles (1), which present the display to the
subject. The goggles are connected to a computer (2) with a linked
video board that generates the multifocal stimulus. Recording
electrodes on the scalp (5) and a ground reference electrode (shown
on the earlobe), detect the VEP signal from one or more recording
channels (in this case four channels are shown). The signals are
conducted to an amplifier (3), before being processed by software
for presentation on the operators display (4). Results can be
compared for each eye, or between the two eyes of a subject, with
respect to normal reference values.
[0032] FIG. 2 shows a schematic of the apparatus for multifocal ERG
recording using virtual reality goggles (1). The set up is the same
as in FIG. 1 except that the recording electrode is placed in
contact with the eye or eyelid. A ground electrode is required
(shown on the earlobe). Only one channel recording is required for
the ERG.
[0033] FIG. 3 is an example of a multi focal multichannel VEP
recording from the right and left eye of a normal subject. FIG. 3A
shows the responses achieved using a conventional screen (22 inch
Hitachi monitor) to present the stimulus. A cortically scaled
dartboard stimulus was generated with 60 different areas of pattern
stimulation using the ObjectiVision perimeter. The trace array
shown in the figure represents the responses generated from each
part of the visual field tested out to 27 degrees of eccentricity
temporally and 34 degrees nasally. For graphics purposes the
central areas are relatively enlarged to show the raw VEP signal
within that area. FIG. 3B shows a multifocal multichannel VEP
recordings from the same normal subject as in FIG. 3A, recorded
using virtual reality goggles to present the same stimulus instead
of the conventional monitor. The same ObjectiVision system was
used. The responses are of similar order of magnitude in the two
techniques, although there is some variation in amplitude across
the field. Due to the specifications of the goggles used, the
display was limited to 21 degrees temporally and 27 degrees
nasally.
[0034] FIG. 4 provides a comparison between subjective perimetry
findings and the objective VEP assessment of the visual field using
virtual reality goggles. FIG. 4A shows the grayscale and pattern
deviation printout from a subjective Humphrey visual field test of
the right eye of a glaucoma patient. An inferior arcuate scotoma
(blind spot) is shown in the visual field. FIG. 4B shows the
multifocal multichannel VEP recording from the same eye as in FIG.
4A, recorded using virtual reality goggles. Analysis of the signals
demonstrates loss of VEP responses corresponding to the inferior
scotoma in FIG. 4A, with more extensive reductions in the superior
field than seen on the Humphrey. The amplitude deviation plot
shades areas according to probability of abnormality when compared
to a reference range of normal values extrapolated from the
conventional screen ObjectiVision system. This suggests that the
technique is capable of detecting visual field loss in glaucoma,
just as it is with the use of the conventional large screen. It may
also demonstrate more significant glaucomatous damage than
suspected on conventional Humphrey field testing. Five glaucoma
patients have been tested with the virtual reality goggles and the
scotomas were detected in all five cases.
[0035] Examination of multifocal VEP data from normal subjects
using conventional CRT monitors demonstrated that the amplitude of
the multi-focal VEP is not age-dependant (contrary to most
electrophysiology parameters, eg the pattern ERG). In fact, some
elderly people produce VEP responses of higher amplitude.
Individual variation in the thickness of the scalp or subcutaneous
tissue may cause inter-individual differences in VEP amplitude due
to variable impedance of bone and fat. Direct measurement of the
thickness or impedance of these tissues is not currently practical.
However, the impedance will also affect the amplitude of the
spontaneous brain activity (EEG) in a similar fashion to the VEP.
To confirm this we conducted a study using the ObjectiVision VEP
perimeter of the correspondence between spontaneous EEG amplitude
(99% confidence interval) and multifocal VEP amplitude (largest
amplitude of a trace). The study included 34 normal subjects. The
results demonstrated a strong correlation between the EEG amplitude
and VEP (correlation coefficient r=0.81). The scatterplot for the
correlation is shown in FIG. 5. An alternative method to measure
background EEG activity is to calculate a Fourier power spectrum of
the EEG.
[0036] Therefore, if the level of spontaneous EEG activity is
calculated during the recording, it provides an indirect measure of
the overall registration of brain signals for that individual for
the electrode positions used. Whilst it is recognised that EEG
amplitude is determined by many additional factors other than
conductivity, it is proposed that scaling of an individual's VEP
responses according to their EEG levels, relative to normal
population EEG values, helps to reduce inter-individual VEP
variability.
[0037] The EEG amplitude is approximately 1000.times. the amplitude
of the VEP, so it is reasonable to assume that the VEP signals
themselves will have little contribution to the raw EEG levels. In
analysis of multifocal VEP recordings the EEG raw data is actually
examined by cross-correlation techniques to extract the VEP
signals. When recording from an individual, the overall level of
the raw EEG (99% confidence interval) as recorded during each run
of the VEP recording, can be used to provide an individual's
scaling factor. The VEP extracted is then scaled by the EEG scaling
factor.
[0038] The value of the technique of the invention of VEP scaling
was confirmed by examining the data from 50 normals. The
coefficient of variation for all 60 visual field test points had a
mean value of 50.1%. When the results were scaled according to
background EEG values the coefficient of variation for all 60
visual field test points was reduced to 28.2%.
[0039] By using EEG scaling, the sensitivity of the test was also
improved. In a study of 60 glaucoma cases using the ObjectiVision
system for multifocal VEP perimetry, several glaucoma cases were
not flagged as abnormal using the unsealed data since the subjects
had overall large signals compared with normal, even though focal
relative reductions could be seen when examining the trace arrays.
With the data scaled according to EEG levels however, these
subjects were identified as having localised reductions in their
VEP amplitudes and the scotomas were flagged appropriately.
[0040] The EEG raw data can contain a large component of alpha
rhythm signals and also spikes of electrocardiogram signals. If
these are not excluded from the scaling factor applied, then some
subjects will have their data inadvertently scaled down lower than
is appropriate. This can introduce false positive results in the
VEP. One technique for rectifying this problem is to examine the
raw signal by Fourier analysis and any alpha-rhythm spikes and
electrocardiogram signals can be identified. These can then be
excluded from the spectrum before calculating a scaling
coefficient.
[0041] Therefore scaling of the VEP amplitude based on amplitude of
spontaneous brain activity eliminates part of the variability
between individuals caused by differences in conductivity of
tissues. This technique has application in analysing multifocal VEP
signals recorded with conventional CRT monitors, plasma screens,
LCD screens, or with virtual reality goggles.
INDUSTRIAL APPLICABILITY
[0042] The method and system of this invention will find wide use
in the medical field, specifically in the field of
ophthalmology.
[0043] The foregoing describes only some embodiments of the
invention and modifications can be made thereto without departing
from the scope of the invention.
REFERENCES
[0044] 1. Baseler H A & Sutter E E. Vis Research 1997;
37(6):675-790 [0045] 2. Klistorner A I, et al Invest Ophthalmol Vis
Sci 1998; 39(6):937-950 [0046] 3. Klistorner A I, et al Aust N Z J
Ophthalmol 1998; 26:91-94. [0047] 4. Graham S L, & Klistorner
A. Aust N Z J Ophthalmol 1998; 26:71-85 [0048] 5. Graham S L, et al
Surv Ophthalmol 1999; 43 (Suppl1):s199-209 [0049] 6. Graham S L
& Klistorner A. Curr Opin Ophthalmol 1999; 10:140-146. [0050]
7. Graham S L, et al J Glaucoma 2000; 9, 10-19 [0051] 8. Kondo, M,
et al Invest Ophthalmol Vis Sci, 1995; 36:2146-2150 [0052] 9.
Vaegan & Buckland L. ANZ J Ophthalmol 1996; 24(2):28-31 [0053]
10. Johnson C A, et al J Glaucoma 2000; 9(AGS abstract):110 [0054]
11. U.S. Pat. No. 4,846,567 (Sutter) [0055] 12. Graham S et al Vol
40 Invest Ophthalmol Vis Sci, 1999, 40 (4) ARVO Abstract #318
[0056] 13. U.S. Pat. No. 5,539,482 (James & Maddess) [0057] 14.
GoldR IEEE Trans, 1967, V.IT-13 (4) 619-621 [0058] 15. Sarwate
& Pursley. Proc IEEE, 1980, Vol 68 (5) 593-619 [0059] 16. Olsen
et al IEEE Trans, 1982, V.IT-28(6) 858-864 [0060] 17. Kamaletdinov
B. Problems of Information Transmission, 1988, Vol 23 (2) 104-107
[0061] 18. Klistorner PCT/AU99/00340
* * * * *